Display options
Cite
Khalkhali M, Sadighian S, Rostamizadeh K, et al. Synthesis and characterization of dextran coated magnetite nanoparticles for diagnostics and therapy. Bioimpacts. 2015;5(3):141-50doi: 10.15171/bi.2015.19.
Khalkhali, M., Sadighian, S., Rostamizadeh, K., Khoeini, F., Naghibi, M., Bayat, N., Habibizadeh, M., & Hamidi, M. (2015). Synthesis and characterization of dextran coated magnetite nanoparticles for diagnostics and therapy. BioImpacts : BI, 5(3), 141-50. https://doi.org/10.15171/bi.2015.19
Khalkhali, Maryam, et al. "Synthesis and characterization of dextran coated magnetite nanoparticles for diagnostics and therapy." BioImpacts : BI vol. 5,3 (2015): 141-50. doi: https://doi.org/10.15171/bi.2015.19
Khalkhali M, Sadighian S, Rostamizadeh K, Khoeini F, Naghibi M, Bayat N, Habibizadeh M, Hamidi M. Synthesis and characterization of dextran coated magnetite nanoparticles for diagnostics and therapy. Bioimpacts. 2015;5(3):141-50. doi: 10.15171/bi.2015.19. Epub 2015 Jun 30. PMID: 26457252; PMCID: PMC4597162.
Copy Download .nbib Format: NLM
Share it on

Bioimpacts. 2015;5(3):141-50. doi: 10.15171/bi.2015.19. Epub 2015 Jun 30.

Synthesis and characterization of dextran coated magnetite nanoparticles for diagnostics and therapy.

BioImpacts : BI

Maryam Khalkhali, Somayeh Sadighian, Kobra Rostamizadeh, Farhad Khoeini, Mehran Naghibi, Nahid Bayat, Mina Habibizadeh, Mehrdad Hamidi

Affiliations

  1. Department of Physics, University of Zanjan, Zanjan, Iran.
  2. Department of Pharmaceutical Biomaterials, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran.
  3. Zanjan Pharmaceutical Nanotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran ; Department of Medicinal Chemistry, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran.
  4. Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  5. Zanjan Pharmaceutical Nanotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran.

PMID: 26457252 PMCID: PMC4597162 DOI: 10.15171/bi.2015.19

Abstract

INTRODUCTION: Expansion of efficacious theranostic systems is of pivotal significance for medicine and human healthcare. Magnetic nanoparticles (MNPs) are known as drug delivery system and magnetic resonance imaging (MRI) contrast agent. MNPs as drug carriers have attracted significant attention because of the delivery of drugs loaded onto MNPs to solid tumors, maintaining them in the target site by an external electromagnetic field, and subsequently releasing drugs in a controlled manner. On the other hand, it is believed that MNPs possess high potential as MRI contrast agents. The aim of this work was to payload curcumin into dextran coated MNPs and investigate their potential as theranostic systems for controlled drug delivery and MRI imaging.

METHODS: MNPs were synthesized as a core and coated with dextran as polymeric shell to provide steric stabilization. Curcumin as anticancer drug was selected to be loaded into NPs. To characterize the synthesized NPs, various techniques (e.g., DLS, FESEM, FT-IR, XRD, and VSM) were utilized. In vitro drug release of curcumin was evaluated at 37˚C at the pH value of 5.4 and 7.4.The feasibility of employment of dextran coated MNPs as MRI contrast agents were also studied.

RESULTS: Formulations prepared from dextran coated MNPs showed high loading (13%) and encapsulation efficiency (95%). In vitro release study performed in the phosphate-buffered saline (PBS, pH= 7.4, 5.4) revealed that the dextran coated MNPs possess sustained release behavior at least for 4 days with the high extent of drug release in acidic media. Vibrating sample magnetometer (VSM) analysis proved the superparamagnetic properties of the dextran coated MNPs with relatively high-magnetization value indicating that they were sufficiently sensitive to external magnetic fields as magnetic drug carriers. Furthermore, dextran coated MNPs exhibited high potential as T2 contrast agents for MRI.

CONCLUSION: Based on our findings, we propose the dextran coated MNPs as promising nanosystem for the delivery of various drugs such as curcumin and MRI contrast agent.

Keywords: Curcumin; Dextran; MRI contrast agent; Magnetic nanoparticles

References

  1. Molecules. 2011 Jun 03;16(6):4567-98 - PubMed
  2. Adv Pharm Bull. 2015 Mar;5(1):115-20 - PubMed
  3. J Hazard Mater. 2007 Aug 25;147(3):792-9 - PubMed
  4. Biochem Pharmacol. 2010 Feb 1;79(3):330-8 - PubMed
  5. Mol Pharm. 2010 Apr 5;7(2):501-9 - PubMed
  6. Science. 2006 Nov 17;314(5802):1107-10 - PubMed
  7. Chem Soc Rev. 2012 Apr 7;41(7):2575-89 - PubMed
  8. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009 Sep-Oct;1(5):530-9 - PubMed
  9. Br J Nutr. 2010 Jun;103(11):1545-57 - PubMed
  10. J Control Release. 2011 Nov 7;155(3):344-57 - PubMed
  11. Biochem Pharmacol. 2008 Dec 1;76(11):1590-611 - PubMed
  12. Clin Cancer Res. 2005 Oct 15;11(20):7490-8 - PubMed
  13. Mol Pharm. 2007 Nov-Dec;4(6):807-18 - PubMed
  14. Int J Pharm. 2007 Feb 7;330(1-2):155-63 - PubMed
  15. J Med Chem. 2006 Jun 1;49(11):3153-8 - PubMed
  16. Biomaterials. 2005 Apr;26(10):1175-83 - PubMed
  17. Colloids Surf B Biointerfaces. 2010 Aug 1;79(1):113-25 - PubMed
  18. Carbohydr Polym. 2014 Jan 30;101:760-8 - PubMed
  19. Altern Med Rev. 2009 Jun;14 (2):141-53 - PubMed
  20. Int J Nanomedicine. 2009;4:115-22 - PubMed
  21. Colloids Surf B Biointerfaces. 2015 Feb 1;126:44-9 - PubMed
  22. Clin Cancer Res. 2008 Oct 1;14(19):6228-36 - PubMed
  23. Science. 2001 Jun 29;292(5526):2469-72 - PubMed
  24. Science. 1994 Mar 18;263(5153):1600-3 - PubMed
  25. Eur J Cancer. 2005 Sep;41(13):1955-68 - PubMed
  26. Science. 2010 Oct 15;330(6002):314-5 - PubMed
  27. Macromol Biosci. 2010 Oct 8;10(10):1141-51 - PubMed
  28. J Mol Biol. 1965 Aug;13(1):238-52 - PubMed
  29. Colloids Surf B Biointerfaces. 2014 May 1;117:406-13 - PubMed
  30. Nanomedicine. 2010 Feb;6(1):153-60 - PubMed
  31. J Pharm Pharm Sci. 2008;11(1):167-77 - PubMed

Publication Types